Chief Scientific Officer and Senior VP R&D, Fosun Pharma USA
Shanghai, CHINA
Dr. Wu is a seasoned executive with >20-years of experience in startup, established biotech, and large pharmaceutical companies. She is currently the Chief Scientific Officer and Senior Vice President of R&D, Fosun Pharma USA. Prior to joining Fosun Pharma in 2018, she was an Entrepreneur-in-Residence at Atlas Venture and Senior Vice President of Preclinical and Early Clinical Development at Delinia, which was acquired by Celgene in 2017. Prior to that, Dr. Wu held various senior leadership positions in the biotech and pharmaceutical industry including Vice President of Biology and Preclinical R&D at Concert Pharmaceuticals, Vice President of Discovery Research at Resolvyx Pharmaceuticals, Executive Director of Cardiovascular Research at the Novartis Institutes for BioMedical Research, and Director of Molecular and Cellular Pharmacology at Millennium Pharmaceuticals. Dr. Wu is an author of over 60 peer-reviewed publications, an inventor on a number of patents, and the recipient of Massachusetts High Tech’s “Women to Watch” award. She has been serving on the advisory council of IBBS/Johns Hopkins School of Medicine and is a member of JHU’s Society of Scholars. Dr. Wu received her Ph.D. in Biochemistry, Molecular Biology and Cell Biology from Northwestern University and completed a postdoctoral fellowship at Johns Hopkins University School of Medicine.

Emerging Opportunities in Global Markets

11:45 AM–5:00 PM Jun 4, 2018 (US - Eastern)

Room 253ABC, Level 2

Katherine AndersenHead of Healthcare Corporate Finance and East/Central Life Science atSilicon Valley Bank Mr. Michael ChanSenior Vice President atHong Kong Exchanges and Clearing Limited (HKEX) Helen ChenManaging Director, Head of L.E.K. China and Asia Life Sciences atL.E.K. Consulting Tony ChenPartner atJones Day Shanghei Joseph DamondExecutive Vice President, International Affairs atBiotechnology Innovation Organization Yuan-Hua DingExecutive Director and Head of External Science & Innovation atPfizer Inc. Monica H.Director, International Affairs atBiotechnology Innovation Organization Edward HuChief Financial Officer and Chief Investment Officers atWuXi AppTec Kewen JinManaging Partner atSerica Partners Alex JungPartner/Managing DIrector atEY-Parthenon Wei LiFounding Partner at6 Dimensions Capital Micah MackisonSenior VP for Corporate Development and Strategy atAssembly Biosciences Wendy PanBoard of Directors atBayHelix Donghui QinDirector of Innovation atFerring Pharmaceuticals Greg ScottFounder and Chairman atChinaBIO Group Victor ShiChairman atBayHelix Alan TurleyDeputy Assistant Secretary for China atU.S. Department of Commerce Jonathan WangSenior VP and Head of Business Development atZai Lab Lijun WuChief Scientific Officer and Senior VP R&D, Fosun Pharma USA atShanghai Henlius Biotech Haishan XiongSenior Vice President for Business Development atFountain Medical Development GE YanfengDirector-General of the Research Department of Social Development atDevelopment Research Center of the State Council (DRC) Debra YuManaging Director atChina Renaissance Securities (US) Inc.